These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9749584)

  • 1. Programmed cell death: does it play a role in Parkinson's disease?
    Burke RE; Kholodilov NG
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S126-33. PubMed ID: 9749584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct nuclear and cytoplasmic localization of caspase cleavage products in two models of induced apoptotic death in dopamine neurons of the substantia nigra.
    Oo TF; Siman R; Burke RE
    Exp Neurol; 2002 May; 175(1):1-9. PubMed ID: 12009755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic expression of cell cycle markers in models of induced programmed cell death in dopamine neurons of the rat substantia nigra pars compacta.
    El-Khodor BF; Oo TF; Kholodilov N; Burke RE
    Exp Neurol; 2003 Jan; 179(1):17-27. PubMed ID: 12504864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmed cell death and Parkinson's disease.
    Burke RE
    Mov Disord; 1998; 13 Suppl 1():17-23. PubMed ID: 9613714
    [No Abstract]   [Full Text] [Related]  

  • 6. CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism.
    Silva RM; Ries V; Oo TF; Yarygina O; Jackson-Lewis V; Ryu EJ; Lu PD; Marciniak SJ; Ron D; Przedborski S; Kholodilov N; Greene LA; Burke RE
    J Neurochem; 2005 Nov; 95(4):974-86. PubMed ID: 16135078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nigrostriatal neuronal death in Parkinson's disease--a passive or an active genetically-controlled process?
    Ziv I; Barzilai A; Offen D; Nardi N; Melamed E
    J Neural Transm Suppl; 1997; 49():69-76. PubMed ID: 9266415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal vulnerability in Parkinson's disease.
    Hirsch EC; Faucheux B; Damier P; Mouatt-Prigent A; Agid Y
    J Neural Transm Suppl; 1997; 50():79-88. PubMed ID: 9120427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extranigral neurodegeneration in Parkinson's disease.
    Samantaray S; Butler JT; Ray SK; Banik NL
    Ann N Y Acad Sci; 2008 Oct; 1139():331-6. PubMed ID: 18991878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease.
    Naoi M; Maruyama W; Akao Y; Yi H
    Neurotoxicol Teratol; 2002; 24(5):579-91. PubMed ID: 12200189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease.
    Sulzer D
    Trends Neurosci; 2007 May; 30(5):244-50. PubMed ID: 17418429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of control mechanisms of dopamine-induced apoptosis--a future approach to the treatment of Parkinson's disease?
    Ziv I; Offen D; Barzilai A; Haviv R; Stein R; Zilkha-Falb R; Shirvan A; Melamed E
    J Neural Transm Suppl; 1997; 49():195-202. PubMed ID: 9266428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medial forebrain bundle axotomy during development induces apoptosis in dopamine neurons of the substantia nigra and activation of caspases in their degenerating axons.
    El-Khodor BF; Burke RE
    J Comp Neurol; 2002 Oct; 452(1):65-79. PubMed ID: 12205710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?
    Hartmann A; Michel PP; Troadec JD; Mouatt-Prigent A; Faucheux BA; Ruberg M; Agid Y; Hirsch EC
    J Neurochem; 2001 Mar; 76(6):1785-93. PubMed ID: 11259496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat.
    Martí MJ; Saura J; Burke RE; Jackson-Lewis V; Jiménez A; Bonastre M; Tolosa E
    Brain Res; 2002 Dec; 958(1):185-91. PubMed ID: 12468044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease.
    McCoy MK; Martinez TN; Ruhn KA; Szymkowski DE; Smith CG; Botterman BR; Tansey KE; Tansey MG
    J Neurosci; 2006 Sep; 26(37):9365-75. PubMed ID: 16971520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of neuronal loss in Parkinson's disease: a neuroanatomical-biochemical perspective.
    Hornykiewicz O
    Clin Neurol Neurosurg; 1992; 94 Suppl():S9-11. PubMed ID: 1320533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
    Anglade P; Vyas S; Javoy-Agid F; Herrero MT; Michel PP; Marquez J; Mouatt-Prigent A; Ruberg M; Hirsch EC; Agid Y
    Histol Histopathol; 1997 Jan; 12(1):25-31. PubMed ID: 9046040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons.
    Herrera AJ; Tomás-Camardiel M; Venero JL; Cano J; Machado A
    J Neural Transm (Vienna); 2005 Jan; 112(1):111-9. PubMed ID: 15599609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental cell death in dopaminergic neurons of the substantia nigra of mice.
    Jackson-Lewis V; Vila M; Djaldetti R; Guegan C; Liberatore G; Liu J; O'Malley KL; Burke RE; Przedborski S
    J Comp Neurol; 2000 Aug; 424(3):476-88. PubMed ID: 10906714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.